Concepedia
Statistics
Publications
14
Citations
1.9K
H-Index
13
Active since
2003
Affiliations
Eli Lilly (United States)(Current)
Wayne State University
Diabeteszentrum Bad Lauterberg
Amplyx Pharmaceuticals (United States)
Justin Northrup is an author at Eli Lilly (United States) specializing in medicine, endocrinology, and diabetes mellitus.
Publications per year
2003–2012
A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study
Michael A. Nauck, D. Kim, Don Johns et al. · Diabetologia · 2006 · 440 citations · Full text
Medicine, Endocrinology, Pharmacotherapy +13
Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial
Michaëla Diamant, Luc Van Gaal, Stephen Stranks et al. · The Lancet · 2010 · 436 citations
Medicine, Endocrinology, Pharmacology +14
Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes
Julio Rosenstock, Leslie J. Klaff, Sherwyn Schwartz et al. · Diabetes Care · 2010 · 226 citations · Full text
Medicine, Endocrinology, Pharmacotherapy +17
Family Medicine Patients' Use of the Internet for Health Information: A MetroNet Study
Kendra Schwartz, T Roe, Justin Northrup et al. · The Journal of the American Board of Family Medicine · 2006 · 216 citations · Full text
Social Sciences, Family Medicine, Health Informatics +15
Exploring the Substitution of Exenatide for Insulin in Patients With Type 2 Diabetes Treated With Insulin in Combination With Oral Antidiabetes Agents
Stephen N. Davis, Don Johns, David Maggs et al. · Diabetes Care · 2007 · 96 citations · Full text
1–5 of 14